Option Care Health, Inc. (NASDAQ:OPCH) Given Average Recommendation of “Moderate Buy” by Analysts

Option Care Health, Inc. (NASDAQ:OPCH) has been given an average rating of “Moderate Buy” by the eight analysts that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is $32.25.

OPCH has been the topic of a number of research reports. JMP Securities restated a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. JPMorgan Chase & Co. raised their target price on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Truist Financial reduced their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th.

Hedge Funds Weigh In On Option Care Health

Several large investors have recently added to or reduced their stakes in OPCH. Freestone Grove Partners LP purchased a new stake in shares of Option Care Health in the fourth quarter worth $17,487,000. Comerica Bank increased its stake in Option Care Health by 13.1% in the 4th quarter. Comerica Bank now owns 1,357,628 shares of the company’s stock worth $31,497,000 after buying an additional 157,198 shares in the last quarter. Schonfeld Strategic Advisors LLC bought a new stake in Option Care Health during the fourth quarter valued at about $533,000. Northern Trust Corp lifted its position in shares of Option Care Health by 11.8% in the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company’s stock valued at $60,934,000 after acquiring an additional 278,158 shares in the last quarter. Finally, Tudor Investment Corp ET AL bought a new position in shares of Option Care Health in the fourth quarter worth about $2,346,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 1.1 %

Shares of Option Care Health stock opened at $31.46 on Wednesday. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.63. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company’s 50 day moving average is $26.86 and its 200 day moving average is $27.90. The company has a market cap of $5.35 billion, a price-to-earnings ratio of 26.44, a price-to-earnings-growth ratio of 2.19 and a beta of 1.35.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.